Science
Mechanism of Action
This synthetic tetrapeptide operates as a multi-functional anti-oedema agent by actively decreasing water retention and inhibiting vascular permeability, thereby preventing fluid accumulation around the eyes. It enhances local microcirculation and aids in toxin removal, which contributes to minimizing dark circles and overall skin dullness. Furthermore, TETRAPEPTIDE-59 exerts anti-glycation effects to protect collagen and stimulates both collagen and elastin production, strengthening the skin’s architecture, improving elasticity, and smoothing the appearance of fine lines and wrinkles. Its anti-inflammatory properties soothe the skin, while also promoting optimal hydration and offering antioxidant protection against free radical damage.
Research
Clinical Evidence
High confidence0.01%
Transparency
Dusting Analysis
Insufficient data available to determine common dusting practices or typical market concentrations in relation to clinically effective dosages.
The Formula
Formulation
Stability
TETRAPEPTIDE-59 demonstrates stability across a broad pH range of 5-8. The product mixture typically maintains a pH between 2 and 6.
Safety
Safety Profile
Acetyl Tetrapeptide-5 is regarded as safe and non-toxic for topical cosmetic use. It is well-tolerated by most skin types, including sensitive skin, and has undergone dermatological testing. Scientific studies suggest a low incidence of side effects, and its components are not classified as hazardous substances under Regulation (EC) No. 1272/2008. Specific regulatory review statuses from bodies like CIR, SCCS, or FDA, or defined maximum concentration guidelines, were not identified in the available research.
Your Skin
Skin Compatibility
Our Assessment
Verdict
TETRAPEPTIDE-59 is a highly valuable peptide for precision skincare, clinically demonstrated to significantly reduce under-eye bags and dark circles while improving skin elasticity and delivering comprehensive anti-aging and soothing benefits.
Related
Similar Ingredients
Finding similar ingredients…